🌱 KidneyEnergy.com

← brief for 2026-08-11 · Slowing decline

SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population-Based Cross-Sectional Study of Uptake of NICE Guidance.

Article C Peer reviewed Observational

Key takeaways

This study checked how often doctors in England prescribe SGLT2 inhibitors, kidney-protective diabetes drugs, in line with national guidance. It found how widely the drugs are actually being used. Because it is a snapshot of records, it describes patterns, not cause and effect.

Who did this work

Muller P · Wray J · Rahman M · Hawkins J · Bakhai C · Cuthbertson DJ · Willans R · Yelland E · Rowark S · Watras M · Sheridan Rains L · Adler AI

Source

Article · PubMed, the drug frontier · 2026 Aug 4
https://pubmed.ncbi.nlm.nih.gov/42552240/